Cargando…
An integrative approach unveils FOSL1 as an oncogene vulnerability in KRAS-driven lung and pancreatic cancer
KRAS mutated tumours represent a large fraction of human cancers, but the vast majority remains refractory to current clinical therapies. Thus, a deeper understanding of the molecular mechanisms triggered by KRAS oncogene may yield alternative therapeutic strategies. Here we report the identificatio...
Autores principales: | Vallejo, Adrian, Perurena, Naiara, Guruceaga, Elisabet, Mazur, Pawel K., Martinez-Canarias, Susana, Zandueta, Carolina, Valencia, Karmele, Arricibita, Andrea, Gwinn, Dana, Sayles, Leanne C., Chuang, Chen-Hua, Guembe, Laura, Bailey, Peter, Chang, David K., Biankin, Andrew, Ponz-Sarvise, Mariano, Andersen, Jesper B., Khatri, Purvesh, Bozec, Aline, Sweet-Cordero, E. Alejandro, Sage, Julien, Lecanda, Fernando, Vicent, Silve |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5321758/ https://www.ncbi.nlm.nih.gov/pubmed/28220783 http://dx.doi.org/10.1038/ncomms14294 |
Ejemplares similares
-
EPCR promotes breast cancer progression by altering SPOCK1/testican 1-mediated 3D growth
por: Perurena, Naiara, et al.
Publicado: (2017) -
PDAC as an Immune Evasive Disease: Can 3D Model Systems Aid to Tackle This Clinical Problem?
por: Narayanan, Shruthi, et al.
Publicado: (2021) -
The Usefulness of Bone Biomarkers for Monitoring Treatment Disease: A Comparative Study in Osteolytic and Osteosclerotic Bone Metastasis Models
por: Martín-Fernández, Marta, et al.
Publicado: (2017) -
The Mir181ab1 cluster promotes KRAS-driven oncogenesis and progression in lung and pancreas
por: Valencia, Karmele, et al.
Publicado: (2020) -
Regulation of osteosarcoma cell lung metastasis by the c-Fos/AP-1 target FGFR1
por: Weekes, Daniel, et al.
Publicado: (2015)